Frost & Sullivan, a US-based growth advisory company, announced on Tuesday that it has recognised WuXi AppTec, a China-based global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, with the 2024 Global CRDMO Company of the Year Award.

The company is being honoured for the eighth consecutive year.

The honour is said to recognise the company's enduring commitment to addressing customer's needs with its unique contract research, development, and manufacturing organisation (CRDMO) model.

Dr Ge Li, WuXi AppTec chairman and CEO, said: "We are delighted to receive the 2024 Global CRDMO Company of the Year Award from Frost & Sullivan. WuXi AppTec is committed to enhancing our unique integrated CRDMO business model to foster collaboration and drive innovation. Our customers deliver groundbreaking treatments to patients around the world, and we are honoured to continue supporting these efforts with the highest quality standards and service."